Investing.com - Financial Markets Worldwide

Procter & Gamble Health Ltd (PROR)

NSE
Symbol
Exchange
Currency
PROR·NSE·INR
PROR·BSE·INR
Currency in INR
5,863.00
+52.50(+0.90%)
Closed·

PROR Financial Summary

Key Ratios

P/E Ratio38.79
Price/Book17.75
Debt / Equity1.42%
Return on Equity37.41%
Dividend Yield3.18%
EBITDA3.03B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
30/06
2021
30/06
2022
30/06
2023
30/06
2024
30/06
Income Statement
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa8,885.9210,087.311,144.112,296.211,512.6
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa5,680.26,842.27,613.68,462.58,087.2
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa1,891.662,172.92,425.62,958.52,791.1
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa1,659.181,7681,925.22,294.72,009.8
Balance Sheet
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa11,757.49,861.68,881.211,011.97,943.6
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa2,273.42,389.72,3193,0392,189.1
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa9,063.47,037.16,164.97,508.95,382.4
Cash Flow
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa-1,779.561,188.381,715.851,727.84
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1,569.132,472.61,695.22,3602,282.9
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa1,097.6-322.7-255.4-215-68.7
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-5,889.4-3,866.3-2,886.3-984.7-4,181.1
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa-3,222.67-1,716.4-1,446.41,160.2-1,966.9
* In Millions of INR (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 151.33%
Dividend Yield
3.18%
Industry Median 0.74%
Annualised payout
185.00
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
May 29, 2025
EPS / Forecast
36.86 / --
Revenue / Forecast
3.14B / --
EPS Revisions
a
a
Unlock
Last 90 days

FAQ

What were Procter & Gamble Health's earnings for the latest quarter?

The Procter & Gamble Health EPS (TTM) is 151.33. Procter & Gamble Health reported sales of 3,109.90, net income of 611.80, and EPS of 36.86 for the latest quarter.

What was Procter & Gamble Health's net income for the latest quarter?

Procter & Gamble Health's net income for the latest quarter was 611.80.

How did Procter & Gamble Health's performance compare year-over-year in the latest quarter?

The company's revenue moved from 3,097.70 in the previous quarter to 3,109.90 in the latest quarter, and net income moved from 909.00 to 611.80 compared to the previous quarter.

What is Procter & Gamble Health's net profit margin on a TTM basis?

Procter & Gamble Health's trailing twelve months (TTM) net profit margin is 17.46%.

How does Procter & Gamble Health's debt to equity ratio compare to industry standards?

Procter & Gamble Health's total debt-to-equity ratio is 1.42%.

What is Procter & Gamble Health's return on investment on a TTM basis?

Procter & Gamble Health's trailing twelve months (TTM) return on investment (ROI) is 37.41%.

Did Procter & Gamble Health gain or lose cash last quarter?

In the latest quarter, Procter & Gamble Health's net change in cash was -844.10 million.

What were Procter & Gamble Health's total assets and liabilities in the latest quarter?

As of the latest quarter, Procter & Gamble Health reported total assets of 7,942.00 million and total liabilities of 2,153.10 million.

How has Procter & Gamble Health's total revenue grown this year?

Procter & Gamble Health's total revenue was 3,097.70 in the previous quarter and 3,109.90 in the latest quarter.

What is Procter & Gamble Health's gross margin on a TTM basis?

Procter & Gamble Health's trailing twelve months (TTM) gross margin is 70.97%.

What was Procter & Gamble Health's revenue per share for the latest quarter?

Procter & Gamble Health's revenue per share for the latest quarter was 296.27.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.